Functional analysis of a novel cell envelope integrity protein in Brucella ovis
Project Number5F32AI174818-02
Former Number1F32AI174818-01
Contact PI/Project LeaderALAKAVUKLAR, MELENE
Awardee OrganizationMICHIGAN STATE UNIVERSITY
Description
Abstract Text
Abstract
The long-term goal of this research is to determine how bacteria maintain cell envelope integrity in the
face of harsh and fluctuating environmental conditions. The cell envelope of Gram-negative bacteria
is composed of the cytoplasmic membrane, peptidoglycan cell wall, and the lipopolysaccharide
(LPS)-containing outer membrane. In the intracellular pathogens, Brucella spp., the composition of
the LPS is critical for virulence and persistence in the host. Our group recently identified a periplasmic
protein of unknown function, named EipA, that is conserved across the class Alphaproteobacteria,
including Brucella. Deletion of eipA in Brucella abortus results in a sensitivity to envelope stressors
and an attenuation of virulence in a mouse model of infection. In Brucella ovis, a species that lacks
smooth LPS, eipA is essential. Conditional depletion of eipA expression in B. ovis causes cells to
form chains; this provides evidence for a role for EipA in cell division. Preliminary cryo-electron
microscopy results indicate that these chained cells fail to control the distance between the
cytoplasmic membrane and outer membrane, resulting in an extended periplasm in eipA-depleted
cells. In aim 1, I will investigate the effect of eipA depletion on the cell envelope architecture.
Specifically, I will test the role of eipA in a) peptidoglycan synthesis and remodeling at the septum and
b) the binding of EipA to phospholipids. In aim 2, I will characterize suppressor mutations that restore
growth to the eipA depletion strain and perform an unbiased pull-down assay with the goal of
identifying the molecular interaction partners of EipA. The experiments described in this proposal will
clarify the role of the essential gene eipA in B. ovis and will add to our understanding of the
alphaproteobacterial cell envelope.
Public Health Relevance Statement
Project Narrative
Bacteria are protected from the surrounding environment by a multi-layer structure known as the cell envelope.
In this study, I will characterize how a recently identified, conserved, and essential protein maintains cell
envelope integrity in the animal pathogen Brucella ovis. This work will provide new understanding of how the
Alphaproteobacteria, which includes the genus Brucella, sustain cellular integrity in the face of inhospitable
environmental conditions.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
193247145
UEI
R28EKN92ZTZ9
Project Start Date
01-September-2023
Project End Date
31-August-2026
Budget Start Date
01-September-2024
Budget End Date
31-August-2025
Project Funding Information for 2024
Total Funding
$74,284
Direct Costs
$74,284
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$74,284
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5F32AI174818-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5F32AI174818-02
Patents
No Patents information available for 5F32AI174818-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5F32AI174818-02
Clinical Studies
No Clinical Studies information available for 5F32AI174818-02
News and More
Related News Releases
No news release information available for 5F32AI174818-02
History
No Historical information available for 5F32AI174818-02
Similar Projects
No Similar Projects information available for 5F32AI174818-02